(Q35200820)

English

Pharmacokinetics of pegfilgrastim

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

7 August 2017

1 reference

Europe PubMed Central

title

Pharmacokinetics of pegfilgrastim (English)

1 reference

stated in

Europe PubMed Central

7 August 2017

1 reference

William C Zamboni

1

1 reference

stated in

Europe PubMed Central

PubMed ID

12921217

retrieved

7 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

stated in

Europe PubMed Central

7 August 2017

1 reference

Europe PubMed Central

7 August 2017

23

1 reference

stated in

Europe PubMed Central

7 August 2017

8 Pt 2

1 reference

stated in

Europe PubMed Central

7 August 2017

9S-14S

1 reference

stated in

Europe PubMed Central

7 August 2017

Pegylation: engineering improved biopharmaceuticals for oncology

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.23.9.9S.32888

retrieved

21 January 2018

Safety and efficacy of pegfilgrastim in patients receiving myelosuppressive chemotherapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.23.9.9S.32888

retrieved

21 January 2018

Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.23.9.9S.32888

retrieved

21 January 2018

Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.23.9.9S.32888

retrieved

21 January 2018

A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.23.9.9S.32888

retrieved

21 January 2018

Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.23.9.9S.32888

retrieved

21 January 2018

Identifiers

DOI

10.1592/PHCO.23.9.9S.32888

1 reference

stated in

Europe PubMed Central

7 August 2017

1 reference

Europe PubMed Central

PubMed ID

12921217

retrieved

7 August 2017

(Q35200820)

Pharmacokinetics of pegfilgrastim

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)